Prediction of anxiety risk in patients with type 2 diabetes mellitus under the influence of unfavourable factors based on multivariate regression analysis
DOI:
https://doi.org/10.32782/2077-6594/2023.4/10Keywords:
anxiety, diabetes mellitus, nursingAbstract
The purpose of the study is to differentiate the risk factors of anxiety level in patients with type 2 diabetes mellitus with/without arterial hypertension (AH) according to the mathematical model of risk factors. Materials and methods. 102 patients participated in the study. Patients with type 2 diabetes and hypertension were included into the 1st group – 52 individuals (42,3 % men and 57,7 % women). Patients with type 2 diabetes without diagnosed hypertension were included into the 2nd group – 50 participants (44,0 % men and 56,0 % women). The Taylor scale of anxiety (supplemented by the scale of sincerity according to V.G. Norakidze) was used to assess the level of anxiety. The statistical processing of the received data was carried out using the Microsoft Excel 2007 spreadsheet and the Statistica 10.0 software package for statistical analysis. Assessment of model acceptability for predicting CRRT was assessed by ANOVA analysis of variance. The results. According to the results of the regression analysis, the significant and common factors of CRRT both groups were gender, duration of TD2 and weight of patients. In addition, age, height, SBP and heart rate were found to be significant factors in the 2nd group. With regard to the questions of Taylor's questionnaire, the significant questions in the 1st group are questions№ 1 “I cannot concentrate on one thing”,№ 2 “I am constantly worried about my material and professional situation”, № 3 “I am often overwhelmed by despair”, № 4 “I lack self-confidence”, № 5 “I am often disappointed”, whereas in the 2nd group – questions № 1 “As a rule, my hands and feet are warm”, № 2 “I am confident in my abilities”, № 3 “Expectations make me nervous”, № 4 “I almost always feel hungr”, № 5 “I lacking self-confidence”, № 6 “I almost never blush”, № 7“I usually work with a lot of effort”. Conclusions. Prediction of CRRT based on multivariate regression analysis is informative, makes it possible to identify important factors affecting the development and course of type 2 diabetes and hypertension, which will allow health care providers to take in time measures for prevention of the progression of anxiety.
References
Грузєва ТС, Паламар БІ, Тукаєв СВ. Особливості психологічних переживань під час надзвичайного стану на прикладі карантину в зв’язку з пандемією COVID-19. Екологічні та гігієнічні проблеми сфери життєдіяльності людини : матеріали наук.-практ. конф. з міжнар. уч. 2023:88–89. URL: http://ir.librarynmu.com/handle/123456789/7095.
Disease, injury, and risk factsheets. Anxiety disorders – Level 3 cause [Internet]. National Institute of Health Metrics Evaluation. 2019 [cited 2023, Nov 10]. URL: https://www.healthdata.org/results/gbdsummaries /2019/anxiety-disorders-level-3-cause.
COVID-19 Mental Disorders Collaborators. Global prevalence and burden of depressive and anxiety disorders in 204 countries and territories in 2020 due to the COVID-19 pandemic. Lancet. 2021;398(10312):1700–1712.
Чабан ОС, Хаустова ОО. Медико-психологічні наслідки дистресу війни в Україні: що ми очікуємо та що потрібно враховувати при наданні медичної допомоги? Український медичний часопис. 2022;4(150)VII/VIII:1–11. URL: https://umj.com.ua/wp/wpcontent/uploads/2022/08/5141.pdf.
Животовська АІ, Ісаков РІ, Рудь ВО, Мартиненко ЯП. Клінічні прояви тривожних розладів із диссомнічними порушеннями залежно від рівня психологічного стресу. Полтавські дні громадського здоров’я : матеріали Всеукр. наук.- практ. конф. з міжнар. уч. 2022:20–22. URL: http://repository.pdmu.edu.ua/bitstream/123456789/18921/1/Zhivotovska_Klinichni_proyavi.pdf.
Юр’єва ЛМ, Вишніченко СІ, Шорніков АВ. Аналіз феноменів тривоги та депресії у перші тижні війни: гендерно-вікові аспекти. Психосоматична медицина та загальна практика. 2022;1:28–31.
Карнаух ЕВ, Шокало ІВ, Шальнова ОІ, Коробко ЕЮ. Ситуативна тривожність студентства як прояв психосоціальної травматизації в реаліях сьогодення України. Science and innovation of modern world. Proceedings of the 4th International scientific and practical conference. Cognum Publishing House. London, United Kingdom. 2022:96–107.
Шемчук ОМ. Медико-психологічна допомога та реабілітація учасників російсько-української війни на госпітальному етапі. Філософсько-соціологічні та психолого-педагогічні проблеми підготовки особистості до виконання завдань в особливих умовах : матеріали наук.-практ. конф. 2022:182–186.
Купновицька ІГ, Романишин НМ, Заволічна МС. Частота і структура психоемоційних розладів в умовах воєнного часу. In The 17th International scientific and practical conference System analysis and intelligent systems for management. Ankara, Turkey. International Science Group. 2023:177–179.
Любінець ЛА, Шведа ГП, Качмарська МО. Ступінь тривожності у середнього медичного персоналу під час воєнного стану в Україні. Україна. Здоров’я нації. 2023;3:80–84.
Daly M, Robinson E. Depression and anxiety during COVID-19. Lancet. 2022;399 (10324). 518 р.
Buttery S, Philip KEJ, Williams P, Fallas A, West B, Cumella A, Cheung C, Walker S, Quint JK, Polkey MI, Hopkinson NS. Patient symptoms and experience following COVID-19: results from a UK-wide survey. BMJ Open Respir Res. 2021;8(1).
Abul Y, Leeder C, Gravenstein S. Epidemiology and Clinical Presentation of COVID-19 in Older Adults. Infect Dis Clin North Am. 2023;37(1):1–26.
Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, Wang B, Xiang H, Cheng Z, Xiong Y, Zhao Y, Li Y, Wang X, Peng Z. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA. 2020;323(11):1061–1069.
Utli H, Vural Doğru B. The effect of the COVID-19 pandemic on self-management in patients with type 2 diabetics. Prim Care Diabetes. 2021;15(5):799–805.
Fisher L, Polonsky W, Asuni A, Jolly Y, Hessler D. The early impact of the COVID-19 pandemicon adults with type 1 or type 2 diabetes: A national cohort study. Journal of Diabetes and its Complications. 2020;34(12).
Souza GFA, Praciano GAF, Neto OCF, Paiva MC, Jesus RPFS, Cordeiro ALN, Souza GA, Junior JRS, Souza ASR. Factors associated with psychic symptomatology in diabetics during the COVID-19 pandemic. Rev. Bras. Saude Mater. Infant. 2021;21(1):177–186.
Ahmed Sayed HA, Fouad AM, Elotla SF, Joudeh AI, Mostafa M, Shah A, Shah J, Mohamed SF. Prevalence and Associated Factors of Diabetes Distress, Depression and Anxiety Among Primary Care Patients With Type 2 Diabetes During the COVID-19 Pandemic in Egypt: A Cross-Sectional Study. Front Psychiatry. 2022;13(937973).
Huang L, Li X, Gu X, Zhang H, Ren L, Guo L, Liu M, Wang Y, Cui D, Wang Y, Zhang X, Shang L, Zhong J, Wang X, Wang J, Cao B. Healt hout comes in people 2 year safter surviving hospitalisation with COVID-19: a longitudinal cohort study. Lancet Respir Med. 2022;10 (9):863–876.
Trikkalinou A, Papazafiropoulou AK, Melidonis A. Type 2 diabetes and quality of life. World J Diabetes. 2017;8(4):120–129.
Lara-Morales A, Gandarillas- Grande A, Diaz-Holgado A, Serrano-Gallardo P. Psychosocial factors in adheren cetopharmacological treatment and diabetes mellitus control in patients over 65. Aten Primaria. 2022;54(5).
Santos MA, Ceretta LB, Réus GZ, Abelaira HM, Jornada LK, Schwalm MT, Neotti MV, Tomazzi CD, Gulbis KG, Ceretta RA, Quevedo J. Anxiety disorders are associated with quality of life impairment in patients with in sulin-dependent type 2 diabetes: a case-control study. Braz J Psychiatry. 2014;36(4):298–304.
Nicolini U. Depression and anxiety during the COVID-19 pandemic. CIRUGIA Y CIRUJANOS. 2020;88(5):530–534.
Сміян СІ, Юськевич ВВ, Сверстюк АС, Слаба УС, Маховська ОС. Багатофакторна регресійна модель прогнозування ризику несприятливого перебігу ревматоїдного артриту, асоційованого з Borrelia burgdorferi. Український ревматологічний журнал. 2023;91(1):1. URL: https://www.rheumatology.kiev.ua/article/17593.
American Diabetes Association. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes-2020. Diabetes Care, Jan, 2020:14–31.
Apovian CM. Obesity: definition, comorbidities, causes, andburden. The American journal of managed care, Jun, 2016;22(7):176–185.
Ryder JR, Northrop E, Rudser KD, Kelly AS, Gao Z, Khoury PR, Kimball TR, Dolan LM, Urbina EM. Accelerated Early Vascular Aging Among Adolescents With Obesity and/or Type 2 Diabetes Mellitus. Journal of the American Heart Association, May 18, 2020;9(10). URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7660865/.
Tsimihodimos V, Gonzalez-Villalpando C, Meigs JB, Ferrannini E. Hypertension and Diabetes Mellitus: Coprediction and Time Trajectories. Hypertension, Mar, 2018;71(3):422–428. URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5877818/.
Carlsson S, Andersson T, Talbäck M, Feychting M. Incidence and prevalence of type 2 diabetes by occupation: results from
all Swedish employees. Diabetologia, Jan, 2020;63(1):95–103. URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6890587/.
